Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · IEX Real-Time Price · USD
24.27
-0.28 (-1.14%)
Mar 28, 2024, 9:45 AM EDT - Market open

Bicycle Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Cash & Equivalents
526.42339.15438.68135.9992.1263.3867.66
Cash & Cash Equivalents
526.42339.15438.68135.9992.1263.3867.66
Cash Growth
55.22%-22.69%222.58%47.63%45.34%-6.33%-
Receivables
24.0421.2111.9114.637.1511.313
Other Current Assets
11.419.027.975.14.882.080.85
Total Current Assets
561.87369.38458.56155.72104.1576.7771.51
Property, Plant & Equipment
27.6832.7717.793.614.351.821.36
Other Long-Term Assets
5.798.463.451.821.73.041.13
Total Long-Term Assets
33.4841.2321.245.436.054.862.49
Total Assets
595.34410.61479.79161.15110.1981.6374
Accounts Payable
13.056.472.721.371.951.892.07
Deferred Revenue
135.1961.8771.3435.165.6614.6414.47
Other Current Liabilities
-78.71-15-37.82-13.391.22-7.59-7.08
Total Current Liabilities
69.5453.3436.2423.138.828.939.45
Long-Term Debt
40.0841.241.9514.931.2500
Other Long-Term Liabilities
114.845.2855.3527.636.9220.3315.29
Total Long-Term Liabilities
154.8886.4897.342.568.1820.3315.29
Total Liabilities
224.41139.83133.5465.691729.2624.74
Total Debt
40.0841.241.9514.931.2500
Debt Growth
-2.72%-1.80%180.99%1093.53%---
Retained Earnings
-511.76-331.1-218.38-151.56-100.55-69.94-48.1
Comprehensive Income
-1.30.39-3.39-3.19-1.54-1.750.07
Shareholders' Equity
370.93270.78346.2595.4693.2-69.83-47.18
Net Cash / Debt
486.34297.95396.73121.0690.8763.3867.66
Net Cash / Debt Growth
63.23%-24.90%227.71%33.23%43.37%-6.33%-
Net Cash Per Share
13.6610.0515.836.328.23144.42203.12
Working Capital
492.33316.04422.32132.5995.3367.8462.06
Book Value Per Share
10.429.1313.824.998.44-159.11-141.64
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).